NDC 51662-1457

DILTIAZEM HCI

Diltiazem Hci

DILTIAZEM HCI is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Diltiazem Hydrochloride.

Product ID51662-1457_99c5813f-1fff-0eaa-e053-2a95a90a751b
NDC51662-1457
Product TypeHuman Prescription Drug
Proprietary NameDILTIAZEM HCI
Generic NameDiltiazem Hci
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2019-12-15
Marketing CategoryANDA / ANDA
Application NumberANDA075853
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameDILTIAZEM HYDROCHLORIDE
Active Ingredient Strength100 mg/1
Pharm ClassesCalcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 51662-1457-1

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (51662-1457-1)
Marketing Start Date2019-12-15
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
DILTIAZEM HYDROCHLORIDE100 mg/1

Pharmacological Class

  • Calcium Channel Antagonists [MoA]
  • Calcium Channel Blocker [EPC]

NDC Crossover Matching brand name "DILTIAZEM HCI" or generic name "Diltiazem Hci"

NDCBrand NameGeneric Name
51662-1335DILTIAZEM HCIDILTIAZEM HCI
51662-1457DILTIAZEM HCIDILTIAZEM HCI

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.